There is no clear definition of the honeymoon period for Parkinson’s disease drug therapy. It just means that taking Parkinson’s medications in the early or middle years of Parkinson’s disease can lead to a more satisfactory and sustained outcome. In fewer drug classes, in smaller doses, and with good symptom control. The quality of life is usually higher during the honeymoon period, and the patient’s normal work and life are not affected. But in this honeymoon period many patients will have some misunderstandings, for example, some patients to the hospital, the doctor gave him to eat some drugs, these drugs are usually relatively small dose, they feel good after taking the drugs, they no longer go to the hospital to see the doctor, or even adjust their own dose, they increase the dose, increase the dose effect and better, he continued to increase the dose. If the dose is relatively large, perhaps this patient is only in the early stages of Parkinson’s, but the drug dose range has reached the middle and late dose, some people eat a year, the honeymoon period is over, it becomes embarrassing and difficult, this time the need to increase the drug and increase the dose, with other drug therapy, although these efforts, but the effect is getting worse. This honeymoon period then becomes very short. I would like to remind all patients that if patients take medication early, the dose meets the needs of life and can work and live normally, keep the dose level low and follow up with specialists regularly, so that this honeymoon period can be kept lasting.